UAE
+919359256675
+919359256675

Tamoxifen Citrate – Trusted Wholesale Supplier In USA, Japan, Australia, Korea, Thailand, Chile


Tamoxifen Citrate – Verified International Supplier for Hospitals & Clinics in USA, Japan, Australia, South Korea, Thailand & Chile- Medswala Pharmacy


Medswala Pharmacy is a leading Indian pharmaceutical exporter, providing TAMOBIX 20 (Tamoxifen Citrate 20mg) as a reliable bulk supply to hospitals, clinics, and healthcare providers worldwide, including Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica).


In oncology and endocrinology, TAMOBIX 20 is a cornerstone therapy. As a Selective Estrogen Receptor Modulator (SERM), it plays a critical role in clinical breast cancer treatment and specialized hormonal management. Medswala Pharmacy ensures quality-assured oncology medications are accessible globally.



 Product Overview: TAMOBIX 20


TAMOBIX 20 contains 20mg of Tamoxifen Citrate, a non-steroidal agent with proven anti-estrogenic properties. It is widely prescribed for estrogen-responsive conditions, delivering both therapeutic efficacy and hormonal balance.

Key Benefits:

  • Clinically proven for ER-positive breast cancer
  • Supports adjuvant therapy to prevent recurrence
  • Safe and effective hormonal management in specialized cases
  • Bulk supply with international export-quality packaging

Therapeutic & Clinical Indications


TAMOBIX 20 is utilized across multiple critical medical pathways:

  1. Breast Cancer Treatment:
    • Gold standard for metastatic and ER-positive breast cancer in women and men
  2. Adjuvant Therapy:
    • Used after surgery or radiation to reduce recurrence risk
  3. Ductal Carcinoma in Situ (DCIS):
    • Prescribed to lower the risk of invasive breast cancer
  4. Infertility Management:
    • Helps induce ovulation in select female infertility cases under specialist supervision
  5. Hormonal Optimization:
    • Manages gynecomastia and specific hormonal imbalances

 Mechanism of Action


TAMOBIX 20 works by targeting estrogen activity in a tissue-specific manner:

  • Estrogen Receptor Blockade: Prevents estrogen from signaling cancer cells to grow in breast tissue
  • Tissue-Specific Action: Acts as anti-estrogen in breast tissue while providing mild estrogenic effects in bones (maintaining density) and liver (supporting lipid profiles)

Dosage and Administration

  • Strength: 20mg tablets
  • Protocol: Typically prescribed as a single daily dose or per oncologist instructions
  • Duration: Often 5–10 years in adjuvant therapy for maximum long-term protection

 Technical Specifications


FeatureDetails
Active IngredientTamoxifen Citrate 20mg
Therapeutic ClassSERM (Oncology / Hormonal Health)
ManufacturerGMP-Certified Facilities, India
PackagingExport-quality blister packs suitable for global shipping

 Global Supply & Export

Medswala Pharmacy specializes in secure international distribution of oncology medications, ensuring full compliance with regulatory requirements.


Key Markets Served:

  • USA & UK (Washington / London): Bulk export to hospitals, oncology centers, and specialized clinics
  • Middle East (Riyadh): Stable supply with complete regulatory compliance
  • Asia-Pacific (Singapore / Bangkok / Canberra): Fast-track delivery to support hospitals and regional distributors
  • Caribbean (Kingston): Dedicated supply chains for pharmaceutical wholesalers and oncology centers

Why Choose Medswala Pharmacy?

  • Trusted international pharmaceutical exporter
  • WHO-GMP certified products
  • Bulk supply options for hospitals, clinics, and distributors
  • End-to-end export documentation and compliance support
  • Timely, secure, and discreet global delivery
  1. 📞 Connect with Medswala Pharmacy– Verified Global Pharma Exporter from India

📱 WhatsApp: +91-9359256675  (🔥 Best Offer – Order on WhatsApp & Save More! 🔥)


💬 WhatsApp Link :  https://wa.me/+919359256675


📧 Email: sales@medswalapharmacy.com


🌐 Website: https://www.indiamedicineexporter.com/


 2026-03-24T10:17:04

Keywords